Octagon Capital Advisors LP Verona Pharma PLC Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
A detailed history of Octagon Capital Advisors LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Octagon Capital Advisors LP holds 2,369,000 shares of VRNA stock, worth $34.3 Million. This represents 5.96% of its overall portfolio holdings.
Number of Shares
2,369,000
Previous 2,369,000
-0.0%
Holding current value
$34.3 Million
Previous $47.1 Million
19.06%
% of portfolio
5.96%
Previous 7.85%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
115Shares Held
60.7MCall Options Held
139KPut Options Held
67.8K-
Nea Management Company, LLC Timonium, MD5.11MShares$73.9 Million5.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.91MShares$56.5 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$54.4 Million1.27% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.61MShares$52.2 Million7.77% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.4MShares$49.1 Million1.23% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $881M
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...